PROSTATE CANCER METASTATIC

This study follows men with advanced prostate cancer who are receiving standard treatment with abiraterone and prednisone. Researchers want to understand if a patient's race or ethnicity affects how well these medications work to control the cancer. The study will track 130 parti…

This is an early-stage trial testing a new, personalized immune cell therapy for people with metastatic colorectal or prostate cancer. Doctors take a patient's own tumor-fighting immune cells, grow large numbers of them in a lab, and give them back to the patient multiple times. …

This large UK trial is testing if adding one of two new treatments to standard hormone therapy helps men live longer with prostate cancer that has spread. One treatment uses highly targeted radiation (SABR) on a few cancer spots, and the other uses a radioactive drug (Lu-PSMA) th…

This study is testing if a 12-week exercise program can reduce the number of prostate cancer cells found in the bloodstream of men with advanced disease. Researchers at Johns Hopkins will enroll 20 men to follow a personalized exercise plan. The main goal is to see if exercise he…

This study is testing a new antibody drug called OM-RCA-01 in people with advanced cancers that have spread and have a specific protein (FGFR1). The main goals are to find a safe dose and see if the drug can slow down tumor growth. About 58 people with certain types of metastatic…

This study is testing if adding a precise, high-dose radiation treatment to standard hormone therapy can better control prostate cancer that has spread to only a few places in the body. It will involve about 118 men whose cancer has spread to 1-3 spots, as seen on a special scan.…

This study is testing if a new drug called opevesostat helps men with advanced prostate cancer live longer than the current standard medications (abiraterone or enzalutamide). It is for men whose cancer has spread and has worsened despite prior hormone therapy and chemotherapy. T…

This study is testing whether a 16-week home exercise program can improve heart health in Black men with prostate cancer who are receiving hormone therapy. Researchers will compare a group doing supervised virtual workouts with a group maintaining their usual activity. The goal i…

This study is testing if two new, more detailed ways of analyzing PET scans can better map where prostate cancer has spread in the body. It will involve 60 men whose cancer has progressed despite standard treatments. The goal is to see if these advanced scan analyses provide a cl…

This study aims to find out if a special type of imaging scan, called a PSMA PET scan, can predict how well different drug treatments will work for men with advanced prostate cancer. Researchers will observe 1,300 patients over 9 years to see if measurements from the scan can for…

This study aims to understand how prostate cancer is diagnosed and treated in Algeria by tracking 2000 patients. Researchers will collect information about patients' backgrounds, symptoms, tests, treatments, and outcomes. The goal is to create a detailed picture of current care p…

This study aims to see if a simple blood test can predict which hormone therapies will work for men with advanced prostate cancer that has spread. Researchers will follow 120 men receiving standard treatment, checking their blood for cancer cells to look for genetic clues linked …